Sort
48,018 grants matching “immunotherapy”
Regulation of Lymphocyte Proliferation and Replicative Capacity
$483,338Richard J. Hodes · Basic Sciences · Z01 · FY2007 · CA
Transfusion Biology and Medicine
$483,334Leslie Eric Silberstein · Boston Children'S Hospital · T32 · FY2007 · HL
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$483,313Jin Chen · Vanderbilt University Medical Center · R01 · FY2023 · CA
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$483,313Jin Chen · Vanderbilt University Medical Center · R01 · FY2022 · CA
Critical Role for Microvasculature in Airway Transplantation
$483,194Mark Robert Nicolls · Palo Alto Veterans Instit For Research · R01 · FY2020 · HL
Effects of FLASH Radiation on Cancer and the Immune Response
$483,153Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Effects of FLASH Radiation on Cancer and the Immune Response
$483,153Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
Radioluminescence dosimetry solution for precision radiation therapy
$483,121Lei Xing · Stanford University · R01 · FY2019 · CA
INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES
$483,061John C Byrd · Ohio State University · P01 · FY2011 · CA
Engineering bZIP family transcription factors for therapeutic T-cell persistence and effector function
$483,041Glenna Wink Foight · Baylor College Of Medicine · R37 · FY2024 · CA
Innate and adaptive defenses against SARS-COV-2 in the oral cavity during acute unvaccinated and breakthrough infections
$483,000Aaron Weinberg · Case Western Reserve University · R56 · FY2022 · DE
Comparative modeling of sarcoma microenvironments for the discovery of biomarkers and tumor vulnerabilities
$482,921Jlenia Guarnerio · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Immunochemotherapy in Visceral Leishmaniasis
$482,909Henry W. Murray · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · AI
Immunochemotherapy in Visceral Leishmaniasis
$482,909Henry W. Murray · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · AI
Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection
$482,876Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2015 · AI
Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection
$482,876Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2018 · AI
Immunotherapy of low grade lymphoid malignancies
$482,780Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Targeting replication stress to engage DNA sensing STING pathway derived anti-tumor immunity to improve the therapeutic outcomes in uterine cancer
$482,771Jean Zhao · Dana-Farber Cancer Inst · P01 · FY2025 · CA
Regulation of encephalitogenic T cells by CRAC channels
$482,707Stefan Feske · New York University School Of Medicine · R01 · FY2020 · AI
Synthetics PNAG and multi-component vaccines against emerging pathogens
$482,707Gerald B Pier · Harvard Medical School · U54 · FY2011 · AI
How RNA binding proteins control effector T cell responses
$482,697Anthony T. Vella · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · CA
PROTEINS IN MULTIPLE MYELOMA AND RELATED BLOOD DISORDERS
$482,688Alan Solomon · University Of Tennessee Knoxville · R01 · FY2007 · CA
The role of plasmacytoid dendritic cells in corneal immunity
$482,650Pedram Hamrah · Schepens Eye Research Institute · R01 · FY2014 · EY
Targeting Neoantigens in Glioblastoma
$482,595Gavin Peter Dunn · Massachusetts General Hospital · R01 · FY2023 · NS
Immunoengineering Strategies for Musculoskeletal Trauma
$482,586Robert E Guldberg · University Of Oregon · R01 · FY2024 · AR